Johnson & Johnson MedTech announced today that it submitted its Ottava surgical robotic system to the FDA for de novo ...
First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY ...
JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients ...
11d
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
Johnson & Johnson today announced that the company has submitted the OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.
The filing comes about a month after competitor Medtronic won FDA approval for the Hugo robotic-assisted surgery system.
To read the full story, subscribe or sign in. MMI gets IDE for robotic microsurgical study in Alzheimer’s Nov. 10, 2025 By Holland Johnson ...
JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback